Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Receivables - Net: 2009-2025

Historic Receivables - Net for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $387.4 million.

  • Nutex Health's Receivables - Net rose 51743.08% to $387.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $387.4 million, marking a year-over-year increase of 51743.08%. This contributed to the annual value of $232.4 million for FY2024, which is 29650.62% up from last year.
  • Per Nutex Health's latest filing, its Receivables - Net stood at $387.4 million for Q3 2025, which was up 51743.08% from $349.2 million recorded in Q2 2025.
  • Nutex Health's 5-year Receivables - Net high stood at $387.4 million for Q3 2025, and its period low was $334958.0 during Q2 2021.
  • Its 5-year average for Receivables - Net is $104.8 million, with a median of $60.7 million in 2024.
  • Per our database at Business Quant, Nutex Health's Receivables - Net soared by 61668234.97% in 2021 and then crashed by 4874.36% in 2022.
  • Nutex Health's Receivables - Net (Quarter) stood at $112.8 million in 2021, then plummeted by 48.74% to $57.8 million in 2022, then increased by 1.43% to $58.6 million in 2023, then surged by 296.51% to $232.4 million in 2024, then skyrocketed by 66.66% to $387.4 million in 2025.
  • Its last three reported values are $387.4 million in Q3 2025, $349.2 million for Q2 2025, and $295.1 million during Q1 2025.